Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BMV/BIIB stock hub

BMV/BIIB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BMV/BIIBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

491.5B

Mexican Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BMV/BIIB

In the news

Latest news · BMV/BIIB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.5

P25 12.7P50 15P75 19.8

Trailing P/E19.9

P25 19.9P50 24.1P75 31.3

ROE7.7

P25 7.7P50 12.3P75 25.2

ROIC10.9

P25 8.8P50 12.7P75 21

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BMV/BIIB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

216

Groups with data

Currency

USD

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	MX
Employees	7,500
Employees Change	-105%
Employees Change Percent	-1.38
Enterprise value	MXN 522.7B
Exchange	Mexican Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-05-10
Market cap	MXN 491.5B
Price	MXN 3,400
Price currency	MXN
Rev Per Employee	23,886,289.88x
Sector	Healthcare
Sic	2836
Symbol	bmv/BIIB
Website	https://www.biogen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.03%
EV Earnings	21.14x
EV/EBIT	11.19x
EV/EBITDA	8.35x
EV/FCF	11.97x
EV/Sales	3.06x
FCF yield	8.89%
Forward P/E	13.49x
P/B ratio	1.46x
P/E ratio	19.87x
P/S ratio	2.74x
PE Ratio10 Y	16.99x
PE Ratio3 Y	19.86x
PE Ratio5 Y	19.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	27.32%
EBITDA Margin	35.38%
FCF margin	24.38%
Gross margin	78.72%
Gross Profit	MXN 141B
Gross Profit Growth	2.83%
Gross Profit Growth Q	0.78%
Gross Profit Growth3 Y	-0.4%
Gross Profit Growth5 Y	-6.2%
Net Income	MXN 24.7B
Net Income Growth	-7.26%
Net Income Growth Q	32.85%
Net Income Growth3 Y	-24.05%
Net Income Growth5 Y	-14.55%
Pretax Margin	16.33%
Profit Margin	13.81%
Profit Per Employee	MXN 3.3M
ROA	5.9
Roa5y	6.65
ROCE	10.25
ROE	7.7
Roe5y	13.26
ROIC	10.92
Roic5y	13.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-3.53%
Cagr1y	19.15%
Cagr3y	-12.12%
Cagr5y	-8.8%
EPS Growth	-8.1
EPS Growth Q	31.1
EPS Growth3 Y	-24.42
EPS Growth5 Y	-13.58
FCF Growth	-0.57%
FCF Growth Q	167.46%
FCF Growth3 Y	19.25%
FCF Growth5 Y	-5.2%
OCF Growth	0.36%
OCF Growth Q	148.94%
OCF Growth10 Y	-4.25%
OCF Growth3 Y	15.58%
OCF Growth5 Y	-6.01%
Revenue Growth	1.23x
Revenue Growth Q	1.93x
Revenue Growth3 Y	-0.55x
Revenue Growth5 Y	-4.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	MXN 0.35
Assets	MXN 531.5B
Cash	MXN 77.2B
Current Assets	MXN 157.9B
Current Liabilities	MXN 51.5B
Debt	MXN 118.3B
Debt EBITDA	MXN 1.8
Debt Equity	MXN 0.35
Debt FCF	MXN 2.71
Equity	MXN 336.2B
Interest Coverage	9.87
Liabilities	MXN 195.3B
Long Term Assets	MXN 373.6B
Long Term Liabilities	MXN 143.7B
Net Cash	MXN -32.7B
Net Cash By Market Cap	MXN -6.65
Net Debt EBITDA	MXN 0.52
Net Debt Equity	MXN 0.1
Net Debt FCF	MXN 0.75
Tangible Book Value	MXN 56.1B
Tangible Book Value Per Share	MXN 380
WACC	4.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.06
Inventory Turnover	1
Net Working Capital	MXN 34.4B
Quick ratio	2.03
Working Capital	MXN 111.6B
Working Capital Turnover	MXN 42.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-30.17%
1Y total return	19.13%
200-day SMA	3,773.5
3Y total return	-32.14%
50-day SMA	2,860.5
50-day SMA vs 200-day SMA	50under200
5Y total return	-36.9%
All Time High	8,322
All Time High Change	-59.14%
All Time High Date	2021-06-11
All Time Low	2,395
All Time Low Change	41.96%
All Time Low Date	2025-08-11
ATR	97.76
Beta	0.2
Ch YTD	8.8
High	3,400
High52	3,400
High52 Date	2026-04-29
High52ch	0%
Low	3,300
Low52	2,395
Low52 Date	2025-08-11
Low52ch	41.96%
Ma50ch	18.86%
Price vs 200-day SMA	-9.9%
RSI	61.78
RSI Monthly	50.38
RSI Weekly	48.31
Sharpe ratio	-0.73x
Sortino ratio	-1.04
Total Return	-1.01%
Tr YTD	8.8
Tr1m	4.65%
Tr1w	3.5%
Tr3m	8.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	MXN 48.9B
Operating Income Growth	4.02
Operating Income Growth Q	-16.14
Operating Income Growth3 Y	-2.11
Operating Income Growth5 Y	-6.25
Operating margin	27.32

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	147,154,881%
Net Borrowing	-5,100,029,440
Shares Insiders	0.2%
Shares Institutions	99.18%
Shares Qo Q	1.16%
Shares Yo Y	1.01%
Short Ratio	3.95

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	MXN 38.4B
Average Volume	109.8x
Bv Per Share	2,278.1
CAPEX	MXN -3B
Ch10y	-30.17
Ch1m	4.65
Ch1w	3.5
Ch1y	19.13
Ch3m	8.8
Ch3y	-32.14
Ch5y	-36.9
Ch6m	23.64
Change	3.5%
Change From Open	3.03
Close	3,285
Days Gap	0.46
Depreciation Amortization	13,760,975,360
Dollar Volume	2,084,200
Earnings Date	2026-04-29
EBIT	MXN 48.9B
EBITDA	MXN 63.4B
EPS	MXN 168
F Score	6
FCF	MXN 43.7B
FCF EV Yield	8.36x
Financing CF	-5,817,496,839
Fiscal Year End	December
Founded	1,978
Goodwill	111,460,293,120
Graham Number	2992.17984
Graham Upside	-11.99
Income Tax	MXN 4.5B
Investing CF	-27,641,673,081
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	MXN 855
Lynch Upside	-74.84
Ma150	3,429.5
Ma150ch	-0.86%
Ma20	3,210.8
Ma20ch	5.89%
Net CF	14,140,825,908
Next Earnings Date	2026-07-29
Open	3,300
P FCF Ratio	11.25
P OCF Ratio	10.52
Position In Range	100
Ppne	56,157,009,920
Price EBITDA	MXN 7.76
Ptbv Ratio	8.77
Relative Volume	5.58x
Revenue	179,147,174,118x
SBC By Revenue	2.96x
Share Based Comp	5,296,500,066
Tax By Revenue	2.53x
Tax Rate	15.47%
Tr6m	23.64%
Volume	613
Z Score	3.12

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BMV/BIIB pay a dividend?

Capital-return profile for this ticker.

Performance

BMV/BIIB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BMV/BIIB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+99.2%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BMV/BIIB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.8

Neutral momentum band

Price vs 200-day MA

-9.9%

50/200-day relationship not available

Beta (5Y)

0.20

Less volatile than the market

Sharpe ratio

-0.73

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BMV/BIIB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bmv/BIIB stock rating?

bmv/BIIB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bmv/BIIB analysis?

The full report lives at /stocks/bmv/BIIB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bmv/BIIB?

The latest report frames bmv/BIIB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bmv/BIIB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.